Abstract
quoted (7).[George P. Hemstreet III] IIIREFERENCES(1) Hemstreet GP 3rd, Yin S, Ma Z, Bonner RB,[Bi W, Rao JY], et al. Biomarker risk assessment and bladder cancer detection in a cohortexposed to benzidine. J Natl Cancer Inst 2001;93:42736.(2) Cordon-Cardo C, Cote RJ, Sauter G. Geneticand molecular markers of urothelial premalignancy and malignancy. Scand J Urol NephrolSuppl 2000;205:8293.(3) Lotan Y, Roehrborn CG. Sensitivity and